Michael Kastan
14Patents
3h-index
23Co-inventors
60Inventor score
Filing activity: Aug 10, 1994 → Jun 2, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6348311B1 | ATM kinase modulation for screening and therapies | Physics | 20 | Expired |
| US5616463A | Methods for determining the presence of functional p53 in mammalian cells | Physics | 18 | Expired |
| US6387640B1 | ATM kinase modulation for screening and therapies | Physics | 15 | Expired |
| US8440695B2 | Use of chloroquine to treat metabolic syndrome | Emerging Cross-Sectional Technologies | 3 | Active |
| US5858679A | Method for determining the presence of functional p53 by measuring GADD45 protein expression | Physics | 3 | Expired |
| US7108992B2 | ATM kinase compositions and methods | Physics | 2 | Expired |
| US8722641B2 | Oligonucleotides which inhibit p53 induction in response to cellular stress | Chemistry; Metallurgy | 1 | Active |
| US7279290B2 | ATM kinase compositions and methods | Emerging Cross-Sectional Technologies | 1 | Expired |
| US6916627B2 | ATM kinase compositions and methods | Emerging Cross-Sectional Technologies | 1 | Expired |
| US12187742B2 | Dual ATM and DNA-PK inhibitors for use in anti-tumor therapy | Chemistry; Metallurgy | 0 | Active |
| US12312588B2 | Nucleolin-targeting aptamers and methods of using the same | Chemistry; Metallurgy | 0 | Active |
| US8933043B2 | Methods for regulation of p53 translation and function | Chemistry; Metallurgy | 0 | Active |
| US11713464B2 | Nucleolin-targeting aptamers and methods of using the same | Chemistry; Metallurgy | 0 | Active |
| US7160692B2 | ATM kinase compositions and methods | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.